It was a busy spring, during which time several of the lab’s grant proposals were funded. Our new grants include:

• Alzheimer’s Association: “Novel estrogen receptor-selective agonists as therapeutics for AD”
• UWM Research Foundation Catalyst Grant: “Assessing EGX854 as a lead compound for alleviating hot flashes and improving memory”
• UWM Research Foundation Bridge Grant: “Estrigenix Therapeutics, Inc: Phase II–Moving next-generation estrogen treatments for menopause forward”

Many thanks to the Alzheimer’s Association and UWM Research Foundation for their support!